Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04538417 · ClinicalTrials.gov registry record · NA
C-RFA of Residual Limb Neuroma
A NA study of Phantom Limb Pain and Neuroma Amputation, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04538417: Completed NA study of Phantom Limb Pain and Neuroma Amputation, sponsored by University of Utah.
NCT04538417 is a NA study of Phantom Limb Pain and Neuroma Amputation that has completed, run by University of Utah. The registered enrollment target is 8 participants, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04538417, a NA study of Phantom Limb Pain and Neuroma Amputation, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess changes in pain, physical function, and health-related quality of life in patients with post-amputation neuroma-associated residual limb pain after cooled radiofrequency ablation.
Primary Outcome
Presented here is the proportion of participants reporting ≥50% improvement in Numeric Rating Scale pain score at 6 months after their cooled radiofrequency ablation procedure. The Numeric Rating Scale was used to quantify neuroma-associated residual limb pain by asking patients to rate their pain intensity on an 11-point scale ranging from 0 to 10, with 0 representing "no pain at all" and 10 representing "the worst pain imaginable".
Conditions Studied
Interventions
- DEVICE Cooled Radiofrequency Ablation
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-10-27 |
| Est. Completion | 2023-08-30 |
| Phase | NA |
What the finished NCT04538417 record still lists
NCT04538417 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 122-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Phantom Limb Pain appearing as the primary indexed condition, and to 1 intervention - of which Cooled Radiofrequency Ablation is the first listed.
NCT04538417 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04538417 about?
NCT04538417 is a clinical study titled "C-RFA of Residual Limb Neuroma". To assess changes in pain, physical function, and health-related quality of life in patients with post-amputation neuroma-associated residual limb pain after cooled radiofrequency ablation.
What is the current status of trial NCT04538417?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-10-27. Estimated completion is 2023-08-30.
What conditions does trial NCT04538417 study?
This clinical trial studies the following conditions: Phantom Limb Pain, Neuroma Amputation.
What interventions are being tested in trial NCT04538417?
The interventions under investigation include: Cooled Radiofrequency Ablation (DEVICE).
Who is sponsoring clinical trial NCT04538417?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04538417 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phantom Limb Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04538417's enrollment target sits among peer trials
8 12th of 12 higher than 1 of 12 other Phantom Limb Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phantom Limb Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Treatments for Postamputation Pain
RECRUITING · NA
-
Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations
RECRUITING · NA
-
Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response
RECRUITING · NA
-
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)
ACTIVE NOT RECRUITING · NA
-
Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
VR to Evaluate Phantom Limb Pain
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI